About BioArray Solutions
BioArray Solutions is a company based in New York (United States) founded in 2001 was acquired by Immucor in March 2008. BioArray Solutions has raised $11.83 million across 2 funding rounds from investors including Immucor. BioArray Solutions operates in a competitive market with competitors including Inflammatix, StrideBio, Agendia, LogicBio and Phase Genomics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioArray Solutions
BioArray Solutions has successfully raised a total of $11.83M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $1.31 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in BioArray Solutions
BioArray Solutions has secured backing from 1 investor. Prominent investors backing the company include Immucor.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Transfusion and transplantation diagnostic products are provided by Immucor.
|
Locked | Locked | Locked |
Investor details for BioArray Solutions
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioArray Solutions
Investment portfolio details for BioArray Solutions
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioArray Solutions
Detailed financials for BioArray Solutions
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioarray Solutions Comparisons
Peer comparison for BioArray Solutions
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioArray Solutions
BioArray Solutions operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inflammatix, StrideBio, Agendia, LogicBio and Phase Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
AAV-based gene therapies for rare diseases are developed.
|
|
| Locked | Locked | Locked |
Genomic diagnostic products for cancer treatment are provided.
|
|
| Locked | Locked | Locked |
Viral vectors are developed for genetic and infectious disease treatments.
|
|
| Locked | Locked | Locked |
Laboratory and computational services for DNA proximity analysis are provided.
|
|
| Locked | Locked | Locked |
Viral immunotherapies are developed for cancer treatment.
|
Detailed competitors of BioArray Solutions
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioarray Solutions
Complete news archive for BioArray Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioArray Solutions
BioArray Solutions was founded in 2001 and raised its 1st funding round 4 years after it was founded.
BioArray Solutions is headquartered in New York, United States. It is registered at New York, New York, United States.
BioArray Solutions is a funded company, having raised a total of $11.83M across 2 funding rounds to date.
BioArray Solutions was founded in 2001 in New York, United States, within the biotechnology sector. Bead-based assays for nucleic acid and protein analysis are developed, along with products for genetic diagnostics and infectious disease profiling. The BeadChip system, featuring encoded microparticles for molecular analysis, has received FDA clearance for an autoantibody profiling assay. The company was acquired by Immucor in March 2008.
BioArray Solutions's top competitors include Inflammatix, Phase Genomics and Genedit.
BioArray Solutions has 1 investor. Key investors include Immucor.